蛋白尿症与肾小球的病变以及西罗莫司(免疫抑制剂)的使用相关。
Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus.
在西罗莫司组中因不良事件而导致停药的也多于继续使用CNI治疗的患者。
Drug discontinuation due to an adverse event was also more frequent in the sirolimus cohort compared to those patients continued on CNI.
Kushwaha和他的同事试验西罗莫司作为可选择的抗增值免疫抑制药物的使用。
Kushwaha and colleagues tested the use of sirolimus as an alternative anti-proliferative immunosuppressant drug.
应用推荐